Skip to content

The Role of a Natural Product, Containing Nanovesicles From Citrus Limon (L.) Juice, on Different CV Risk Factors

Effects of the Natural Supplement CitraVes Containing Nanovesicles Delivered From Citrus Limon (L.) Juice on Cardio-metabolic Risk Factors in Subjects With Metabolic Syndrome

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04698447
Enrollment
60
Registered
2021-01-06
Start date
2019-03-28
Completion date
2021-02-28
Last updated
2021-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers, Metabolic Syndrome

Keywords

cardiovascular risk, extracellular vesicles, metabolic parameters, nutraceuticals, Citrus limon (L.)

Brief summary

Clinical trial about beneficial effects of natural supplement in a spray-dried formulation, citraVes™, obtained from Citrus Limon (L.) juice on general body health.

Detailed description

This is one randomized, double-blind, placebo-controlled study. The aim of the present study is to investigate the role of a natural product, citraVes™ on several cardiovascular risk factors. The research hypothesis is to evaluate whether this natural supplement containing nanovesicles delivered from Citrus Limon (L.) juice (Navhetec S.R.L., Palermo, Italy) may improve different cardio-metabolic parameters in subjects with the metabolic syndrome. All subjects will be evaluated at baseline, after 1 month and after 3 and 6 months of supplementation with natural product or placebo.

Interventions

DIETARY_SUPPLEMENTNatural supplement containing nanovesicles delivered from Citrus Limon (L.) juice_MetS

20 eligible subjects with the metabolic syndrome (MetS) will take natural supplement containing a spray-dried formulation of citraVes™, directly in the mouth, without water, to be dissolved preferably under the tongue, at a stable dose of one sachet a day (1000 mg/day) for 6 months and as add-on therapy to the ongoing treatment, maintained at fixed doses for the entire study.

20 eligible subjects with the metabolic syndrome will take placebo in a spray-dried formulation (without any active ingredients) directly in the mouth, without water, to be dissolved preferably under the tongue, at a stable dose of one sachet a day for 6 months, as add-on therapy to the ongoing treatment, maintained at fixed doses for the entire study.

DIETARY_SUPPLEMENTNatural supplement containing nanovesicles delivered from Citrus Limon (L.) juice_HS

20 eligible healthy subjects (HS) will take natural supplement containing a spray-dried formulation of citraVes™, directly in the mouth, without water, to be dissolved preferably under the tongue, at a stable dose of one sachet a day (1000 mg/day) for 6 months, maintained at fixed doses for the entire study.

Sponsors

University of Palermo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Masking description

double-blind study

Intervention model description

placebo-controlled study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* men and women \> 18 years old; * body mass index (BMI) \> 25 kg/m²; * subjects who are able to swallow; * subjects who are willing to participate in the study and therefore, to sign informed consent prior to any study procedure; * the inclusion criteria for patients with MetS was also the diagnosis of MetS, as defined by international consensus \[Alberti KG, et al. Circulation. 2009; 120:1640-5\].

Exclusion criteria

* pregnancy or the willingness to become pregnant; * severe renal or hepatic impairment; * known severe infections (such as HIV, HBV, HCV) * any neoplasms; * the

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in Plasma Lipids in Healthy Subjects3 monthsEffect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on low-density lipoprotein cholesterol (LDL-C), total cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-C) (mmol/l).
Change from Baseline in Plasma Lipids in Subjects with Metabolic Syndrome6 monthsEffect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on low-density lipoprotein cholesterol (LDL-C), total cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-C) (mmol/l).

Secondary

MeasureTime frameDescription
Change from Baseline in Body Mass Index (BMI) in Healthy Subjects3 monthsEffect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on body weight (kg) and height (m) that will be combined to report BMI in kg/m\^2.
Change from Baseline in Body Mass Index (BMI) in Subjects with Metabolic Syndrome6 monthsEffect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on body weight (kg) and height (m) that will be combined to report BMI in kg/m\^2.
Change from Baseline in Glycemia in Healthy Subjects3 monthsEffect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on plasma glycemia (mmol/l).
Change from Baseline in Glycemia in Subjects with Metabolic Syndrome6 monthsEffect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on plasma glycemia (mmol/l).
Change from Baseline in Waist Circumference in Healthy Subjects3 monthsEffect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on waist circumference (cm).
Change from Baseline in Glycated Haemoglobin in Subjects with Metabolic Syndrome6 monthsEffect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on glycated haemoglobin (HbA1c) (%).
Change from Baseline in Subclinical Atherosclerosis in Subjects with Metabolic Syndrome6 monthsEffect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on subclinical atherosclerosis assessed by carotid intima-media thickness (CIMT) (mm).
Change from Baseline in Plasma Cytokines in Subjects with Metabolic Syndrome6 monthsEffect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on plasma cytokines (inflammatory markers) (pg/ml), that will be assessed using available enzyme-linked immunosorbent assay (ELISA) kits.
Change from Baseline in Glycated Haemoglobin in Healthy Subjects3 monthsEffect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on glycated haemoglobin (HbA1c) (%).
Change from Baseline in Waist Circumference in Subjects with Metabolic Syndrome6 monthsEffect of natural supplement containing nanovesicles from Citrus Limon (L.) juice on waist circumference (cm).

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026